1.
Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction
2.
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years